(Q37865060)

24 August 2017

1 reference

title

Obesity and psoriasis: body weight and body mass index influence the response to biological treatment (English)

1 reference

24 August 2017

0 references

1

L Puig

1 reference

24 August 2017

language of work or name

1 reference

15 April 2011

1 reference

Journal of the European Academy of Dermatology and Venereology

24 August 2017

published in

1 reference

24 August 2017

volume

25

1 reference

24 August 2017

issue

9

1 reference

24 August 2017

page(s)

1007-1011

1 reference

Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Incidence and risk factors for psoriasis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

21 January 2018

Adipokines and psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

The effect of weight on the efficacy of biologic therapy in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Remission of psoriasis after open gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.04065.X

10.1111/J.1468-3083.2011.04065.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference